Search - tctmd.com

Displaying 21 - 40 of 75

Sort: Relevancy | Date

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

SAVR After Failed TAVI on the Rise, With High Mortality

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presentation STS 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presenter: Jad Malas

January 27, 2024

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

News Daily News

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Yael L. Maxwell

January 22, 2024

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

August 21, 2023

Abbott to Stop Making Trifecta Surgical Aortic Valves

News Daily News

Abbott to Stop Making Trifecta Surgical Aortic Valves

Michael O'Riordan

July 31, 2023

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

February 27, 2023

Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes

News Daily News

Adopting TEER Doesn’t Put a Dent in Surgical MV Repair Volumes

February 07, 2023

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

January 20, 2023

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.